Epirubicin and doxorubicin: a comparison of their characteristics, therapeutic activity and toxicity.
Launchbury
A P
AP
Farmitalia Carlo Erba Ltd, St Albans, UK.
Habboubi
N
N
D000971:Antineoplastic Combined Chemotherapy Protocols; D004317:Doxorubicin / Q000008:administration & dosage / Q000009:adverse effects / Q000737:chemistry / Q000378:metabolism / Q000494:pharmacology / Q000627:therapeutic use; D015251:Epirubicin / Q000008:administration & dosage / Q000009:adverse effects / Q000737:chemistry / Q000378:metabolism / Q000494:pharmacology / Q000627:therapeutic use; D006801:Humans; D009369:Neoplasms / Q000188:drug therapy
D015251:Epirubicin; D004317:Doxorubicin